Finasteride Tablet, Film Coated
Product Images NDC 50090-6941

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 50090-6941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Symptom Score In A Long-term Efficacy And Safety Study (Finasteride Fig1)

This text provides information about the mean change from baseline in a study conducted to evaluate the efficacy and safety of a treatment. The data is presented in Figure 1, displaying symptom scores over a period of 4 years. The study includes a comparison between a placebo group and a group receiving finasteride. The specific values for each year are provided for both groups.*

FDA Label Image

Figure 2 Percent Of Patients Having Surgery For Bph, Including Turp (Finasteride Fig2)

FDA Label Image

Figure3 (Finasteride Fig3)

Figure 3 shows the percentage of patients who developed acute urinary retention, both spontaneously and precipitated. The graph depicts the observation time in months on the x-axis and the percentage of patients on the y-axis. The data includes two groups: the Finasteride group and the Placebo group. The Finasteride group had a lower percentage of patients developing acute urinary retention compared to the Placebo group. The graph also displays the number of events cumulatively over time for each group, as well as the number of patients at risk each year.*

FDA Label Image

Figure4 (Finasteride Fig4)

FDA Label Image

Figure5 (Finasteride Fig5)

Figure 5 shows the cumulative incidence of a 4-point rise in AUA Symptom Score by treatment group. The graph displays the percent of participants experiencing this event over time, with the x-axis representing years from randomization and the y-axis indicating the percent with the event. The graph spans from 0 to 55 years.*

FDA Label Image

Chemical Structure (Finasteride Str)

FDA Label Image

Label Image (Lbl500906941)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.